# Xcellerex

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/xcellerex

- Industry: Pharmaceuticals
- Headquarters: Marlborough, US
- Website: www.xcellerex.com
- Total disclosed funding: $42M
- Latest round: Series C (Oct 11, 2007)
- Investors on record: 3

## About

Xcellerex, Inc. develops biomolecule manufacturing technologies and platforms. Its products and services include FlexFactory, a bioprocess manufacturing platform that handles the production of bioproducts, such as vaccines, yeast, and insulins; XDR single-use bioreactors, which are integrated systems for GMP clinical and commercial production.

## Funding rounds

- Series C, Oct 11, 2007, $31M — Kleiner Perkins, VantagePoint Capital, Shenzhen Capital Real Estate Fund
- Series B, Jan 29, 2007, $11M — Kleiner Perkins, Shenzhen Capital Real Estate Fund

## Investors

- Kleiner Perkins (https://capitalatlas.ai/funds/kleiner-perkins) — Series B, Series C
- Shenzhen Capital Real Estate Fund (https://capitalatlas.ai/funds/shenzhen-capital-real-estate-fund) — Series B, Series C
- VantagePoint Capital (https://capitalatlas.ai/funds/vantagepoint-capital) — Series C